The BioMarker Development (BMD) department in NIBR Translational Medicine delivers integrated biomarker plans as a core component of the clinical trial team. We leverage diverse clinical, laboratory, and operational knowledge and experience to design, execute, and oversee biomarker plans in clinical studies. Our goal is to identify and measure the most impactful biomarkers at time-points that help guide strategic decision making for early-stage compounds.
Biomarker solutions are critical in clinical development to:
Define the stage/subtype of the disease
Predict the effect (safety and/or efficacy) of medication
Select a group of patients who would benefit most from a given therapy
Identify opportunities for development of companion diagnostics
Biomarker solutions are critical in clinical development to investigate a disease; profile a compound’s mechanism of action, potency and likely side effects; identify factors that may predict therapeutic response; and develop parallel or expanded indications for the compound. Biomarkers are an essential component for the progression of compounds across all therapeutic areas and stages of development. Our new fellow will become part of a team of over ninety experts in areas that include biomarker operations, clinical imaging, data science, genetics, vendor management, and assay development
Specific responsibilities of the Fellows will include:
Represent BMD on clinical trial teams, work with Biomarker Experts and Clinical Trial Leaders to develop biomarker plans for implementation in clinical studies
Develop relevant study documentation, including clinical protocol biomarker sections, lab manuals, informed consent forms, and biomarker study budgets
Work with internal and external stakeholders to resolve issues related to biomarker samples in ongoing clinical trials
Acquire knowledge of potential ethical issues related to biomarker sample collection and analysis, and devise solutions that satisfy both ethical concerns and study objectives
Gain familiarity with innovative biomarker technologies used in clinical research
Lead and contribute to process improvement projects, technology evaluations, and other initiatives across NIBR sites
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS Fluid Review application portal. Visit https://mcphs.fluidreview.com/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portalby December 2nd 23:59 EST, 2019:
Letter of intent
Unofficial college transcript
Contact information of three references for recommendations
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
After ASHP Midyear Clinical Meeting
The three letters of recommendation must be submitted by the three provided contacts no later than December 16th
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance and relocation reimbursement.
About MCPHS University/Novartis Institutes for BioMedical Research
The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis. We are committed to discovering innovative medicines to treat diseases with high unmet medical need. With more than 6,000 scientists and physicians around the world, our open and entrepreneurial culture encourages collaboration as we work to push the boundaries of science to change the practice of medicine.